Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics

• Ella Willenbacher,

  Affiliations Medical University of Innsbruck, Internal Medicine V—Hematology and Oncology, Innsbruck, Austria, Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL–Center for Personalized Cancer Medicine, Innsbruck, Austria

  ⨯
• Roman Weger,

  Affiliation Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL–Center for Personalized Cancer Medicine, Innsbruck, Austria

  ⨯
• Ursula Rochau,

  Affiliations Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL–Center for Personalized Cancer Medicine, Innsbruck, Austria, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT—University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria

  ⨯
• Uwe Siebert,

  Affiliations Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL–Center for Personalized Cancer Medicine, Innsbruck, Austria, Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT—University for Health Sciences, Medical Informatics and Technology, Hall in Tirol, Austria, Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America, Center for Health Decision Science, Department of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Wolfgang Willenbacher ,

  * E-mail: Wolfgang.Willenbacher@tirol-kliniken.at

  Affiliations Medical University of Innsbruck, Internal Medicine V—Hematology and Oncology, Innsbruck, Austria, Area 4 Health Technology Assessment and Bioinformatics, ONCOTYROL–Center for Personalized Cancer Medicine, Innsbruck, Austria

  ⨯
• Austrian Myeloma Registry (AMR)

  ¶The complete list of AMR participants & coordinating physicians can be found in S1 File.

  ⨯